LEXX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Lexaria Bioscience Corp

NASDAQ | LEXX

0.82

USD

$0.00

(

0.00%

)

At Close (As of Oct 16, 2025)

$18.85M

Market Cap

-

P/E Ratio

-0.68

EPS

$2.91

52 Week High

$0.77

52 Week Low

HEALTHCARE

Sector

LEXX Chart

Recent Chart
Price Action

LEXX Technicals

Tags:

LEXX Earnings

Yearly Income Statement (As of Aug 31, 2024)

Field Value (USD)
Gross Profit $459K
Total Revenue $464K
Cost Of Revenue $4.8K
Costof Goods And Services Sold $4.8K
Operating Income -$5.8M
Selling General And Administrative $3.9M
Research And Development $2.4M
Operating Expenses $6.2M
Investment Income Net -
Net Interest Income $14K
Interest Income $14K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $76K
Income Before Tax -$5.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.8M
Comprehensive Income Net Of Tax -
Ebit -$5.8M
Ebitda -$5.7M
Net Income -$5.8M

Revenue & Profitability

Earnings Performance

LEXX Financials

yearly Balance Sheet (As of Aug 31, 2024)

Field Value (USD)
Total Assets $8.9M
Total Current Assets $7.9M
Cash And Cash Equivalents At Carrying Value $6.5M
Cash And Short Term Investments $6.5M
Inventory -
Current Net Receivables $154K
Total Non Current Assets $970K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $517K
Intangible Assets Excluding Goodwill $517K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $56K
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $1.2M
Total Current Liabilities $1.1M
Current Accounts Payable $371K
Deferred Revenue -
Current Debt -
Short Term Debt $28K
Total Non Current Liabilities $109K
Capital Lease Obligations $137K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $137K
Other Current Liabilities $687K
Other Non Current Liabilities -
Total Shareholder Equity $8M
Treasury Stock -
Retained Earnings -$52M
Common Stock $16K
Common Stock Shares Outstanding $12M

yearly Cash Flow (As of Aug 31, 2024)

Field Value (USD)
Operating Cashflow -$5M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $76K
Capital Expenditures $43K
Change In Receivables -
Change In Inventory $0
Profit Loss -
Cashflow From Investment -$189K
Cashflow From Financing $10M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$5.8M

yearly Income Statement (As of Aug 31, 2024)

Field Value (USD)
Gross Profit $459K
Total Revenue $464K
Cost Of Revenue $4.8K
Costof Goods And Services Sold $4.8K
Operating Income -$5.8M
Selling General And Administrative $3.9M
Research And Development $2.4M
Operating Expenses $6.2M
Investment Income Net -
Net Interest Income $14K
Interest Income $14K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $76K
Income Before Tax -$5.8M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$5.8M
Comprehensive Income Net Of Tax -
Ebit -$5.8M
Ebitda -$5.7M
Net Income -$5.8M

LEXX News

LEXX Profile

Lexaria Bioscience Corp Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lexaria Bioscience Corp. is a pioneering biotechnology firm headquartered in Kelowna, Canada, specializing in the enhancement of health benefits associated with CBD through its proprietary DehydraTECHâ„¢ drug delivery technology. This patented innovation significantly improves the bioavailability of active pharmaceutical ingredients, establishing Lexaria as a leader in the rapidly evolving cannabinoid sector. Committed to extensive research and development, the company seeks to optimize cannabinoid applications across healthcare and wellness markets, addressing diverse consumer health needs while driving growth in the burgeoning cannabis industry.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
-17.95%
$0.33
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
CLSK
-13.92%
$19.97
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
-17.95%
$0.33
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
F
-0.17%
$11.74
SCNX
-17.63%
$0.58
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
CLSK
-13.92%
$19.97
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.